About N-acetylaspartylglutamate synthase A
N-acetylaspartylglutamate synthase A (RIMKLA) is a protein
from Homo sapiens identified by UniProt accession
Q8IXN7, 391 residues long.
MolForge cross-references it against 0 known binders and
18 disease associations.
Target properties
| Protein name | N-acetylaspartylglutamate synthase A |
| UniProt accession | Q8IXN7 |
| Gene | RIMKLA |
| Organism | Homo sapiens |
| Length | 391 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (18)
Diseases linked to this target (Open Targets).
- leukocyte count · score 0.07
- systolic blood pressure · score 0.05
- Barrett's esophagus · score 0.04
- pulse pressure measurement · score 0.03
- appendicular lean mass · score 0.03
- nonpapillary renal cell carcinoma · score 0.02
- Crohn's disease · score 0.01
- memory impairment · score 0.01
- Hepatic steatosis · score 0.01
- hepatocellular carcinoma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IXN7-F1 | alphafold | PREDICTED | 80.25 | — |
Amino-acid sequence (391 residues)
MCSQLWFLTD RRIREDYPQV QILRALRQRC SEQDVRFRAV LMDQIAVTIV GGHLGLQLNQ KALTTFPDVV LVRVPTPSVQ SDSDITVLRH LEKLGCRLVN RPQSILNCIN KFWTFQELAG HGVPMPDTFS YGGHEDFSKM IDEAEPLGYP VVVKSTRGHR GKAVFLARDK HHLSDICHLI RHDVPYLFQK YVKESHGKDI RVVVVGGQVI GSMLRCSTDG RMQSNCSLGG VGVKCPLTEQ GKQLAIQVSN ILGMDFCGID LLIMDDGSFV VCEANANVGF LAFDQACNLD VGGIIADYTM SLLPNRQTGK MAVLPGLSSP REKNEPDGCA SAQGVAESVY TINSGSTSSE SEPELGEIRD SSASTMGAPP SMLPEPGYNI NNRIASELKL K
Explore N-acetylaspartylglutamate synthase A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets